IR in T2DM patients has also been linked to a rise in pro-inflammatory markers such as interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and C-reactive protein in the bloodstream [39,60,61]. Here, IL6 is linked to type 2 diabetes mellitus.